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(57)	 ABSTRACT
The present invention involves a light system for stimulating
orregulating neuroendocrine, circadian, andphotoneural sys-
tems in mammals based upon the discovery of peak sensitiv-
ity ranging from 425-505 mu; a light meter system for quan-
tifying light which stimulates or regulates mammalian
circadian, photoneural, and neuroendocrine systems. The
present invention also relates to translucent and transparent
materials, and lamps or other light sources with or without
filters capable of stimulating or regulating neuroendocrine,
circadian, and photoneural systems in mammals. Addition-
ally, the present invention involves treatment of mammals
with a wide variety of disorders or deficits, including light
responsive disorders, eating disorders, menstrual cycle disor-
ders, non-specific alerting and performance deficits, hor-
mone-sensitive cancers, and cardiovascular disorders.
9 Claims, 12 Drawing Sheets
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PHOTORECEPTOR SYSTEM FOR	 tion and function of a central nervous system circadian oscil-
MELATONIN REGULATION AND	 lator: the suprachiasmatic hypothalamic nucleus. Federation
PHOTOTHERAPY
	
	
Proceedings 42:2783-2789; Klein D C, Moore RY, Reppert S
M, eds. Suprachiasmatic Nucleus: The Mind's Clock. Oxford:
CROSS REFERENCE TO RELATED	 5 Oxford University Press, 5-456, 1991; Morin L P (1994) The
APPLICATIONS
	
	
circadian visual system. Brain Res Brain Res Rev 19:102-
127). By this pathway, light and dark cycles are perceived
This application claims priority under 35 U.S.C. §119 	 through the mammalian eyes, entrain SCN neural activity
based upon U.S. Provisional Patent Application No. 60/203, 	 and, in turn, entrain the rhythmic secretion of melatonin from
308 filed May 10, 2000 and upon U.S. Provisional Patent io the pineal gland. In virtually all species, melatonin secretion
Application No. 60/228,493 filed Aug. 28, 2000. 	 is high during the night and low during the day (Reiter, 1991;
Arendt, 1998).
GOVERNMENT RIGHTS IN THE INVENTION 	 In addition to entraining pineal rhythms, light exposure can
acutely suppress melatonin secretion (Rollag and Niswender,
This invention was made with government support under 15 1976; Lewy et al., 1980). A well-defined multisynaptic neural
grants from NIH ROINS36590 awarded by the National	 pathway extends from the SCN to the pineal gland, which
Institutes of Health; NSBIR/NASA HPF.002.08 (to GCB) 	 transmits information about light and circadian time for
awarded by the National Space Biology Research Institute in 	 entraining the rhythmic production and secretion of the hor-
cooperation with the National Aeronautics and Space Admin- 	 mone melatonin. (Moore R Y, Lenn N J. J Comp Neurol
istration; NSF IBN9809916 awarded by the National Science 20 146:1-14, 1972; Klein D C et al., eds. Suprachiasmatic
Foundation; and DOD R070HY (to MDR) awarded by the	 Nucleus: The Mind's Clock 5-456, 1991; Schwartz W J,
Department of Defense. The government has certain rights in	 Busis N A, Hedley-Whyte E T. A discrete lesion of ventral
the invention.	 hypothalamus and optic chiasm that disturbed the daily tem-
perature rhythm. JNeurol 233:1-4,1986; Arendt J. Melatonin
FIELD OF THE INVENTION	 25 and the pineal gland: influence on mammalian seasonal and
circadian physiology. Rev Reprod3: 13 -22, 1998),Inaddition
The present invention generally relates to the fields of 	 to synchronizing pineal indolamine circadian rhythms, ocular
neurology, neuroscience, and endocrinology and to light sys- 	 exposure to light during the night can acutely suppress mela-
tems, light meters, lamps, filters, transparent and translucent 	 tonin synthesis and secretion (Klein D C, Weller J L (1972)
materials, and methods of treating a variety of mammalian 3o Rapid light-induced decrease in pineal serotonin N-acetyl-
disorders and, more particularly to a light system for stimu- 	 transferase activity. Science 177:532-533; Lewy A J, Wehr T
lating or regulating neuroendocrine, circadian, and photoneu- 	 A, Goodwin F K, Newsome D A, Markey S P (1980) Light
ral systems in mammals based upon the discovery of peak 	 suppresses melatonin secretion in humans. Science 210:
sensitivity ranging from 425-505 mu; a light meter system for 	 1267-1269). Light-induced melatonin suppression is a well-
quantifying light which stimulates mammalian circadian, 35 defined, broadly used marker for photic input to the RHT and
photoneural, and neuroendocrine systems; translucent and 	 SCN (Klein D C, 1991; Arendt J (1998) Melatonin and the
transparent materials, and lamps or other light sources with or 	 pineal gland: influence on mammalian seasonal and circadian
without filters stimulating or regulating neuroendocrine, cir- 	 physiology. Rev Reprod 3:13-22; Brainard G C, Rollag M D,
cadian, and photoneural systems in mammals; and treatment 	 Hanifin J P (1997) Photic regulation of melatonin in humans:
of mammals with a wide variety of disorders or deficits, 40 ocular and neural signal transduction. J Biol Rhythms
including light responsive disorders, eating disorders, men- 	 12:537-546; Lucas R J, Foster R G (1999) Neither functional
strual cycle disorders, non-specific alerting and performance	 rod photoreceptors nor rod or cone outer segments are
deficit, hormone-sensitive cancers, and cardiovascular disor- 	 required for the photic inhibition of pineal melatonin. Endo-
ders.	 crinology 140:1520-1524).
45	 Previously, it has not been known what photoreceptors
BACKGROUND OF THE INVENTION
	
	
transduce light stimuli for circadian regulation. Studies on
animals with hereditary or light-induced retinal degeneration
Light is the primary stimulus for regulating circadian 	 have raised the possibility that neither the rods nor the cones
rhythms, seasonal cycles, and neuroendocrine responses in 	 used for vision participate in light-induced melatonin sup-
many species including humans (Klein et al., 1991; Wehr, 50 pression, circadian locomotor phase-shifts, or photoperiodic
1991). Further, clinical studies have demonstrated that light 	 responses (Lucas, 1999; Webb S M, Champney T H, Lewin-
therapy is effective for treating selected affective disorders, 	 ski A K, Reiter R J (1985) Photoreceptor damage and eye
sleep problems, and circadian disruptions (Wetterberg, 1993;	 pigmentation: influence on the sensitivity of rat pineal
Lam, 1998). Previously, the ocular photoreceptors which 	 N-acetyltransferase activity and melatonin levels to light at
transduce light stimuli for circadian regulation and the clini-  55 night. Neuroendocrinology 40:205-209; Goto M, Ebihara S
cal benefits of light therapy have been unknown. 	 (1990) The influence of different light intensities on pineal
Nonetheless, scientists have been deeply involved in elu- 	 melatonin content in the retinal degenerate C3H mouse and
cidating the physiologic and functional anatomic features 	 the normal CBA mouse. Neurosci Lett. 108:267-272; Foster
associated with light and vision. In fact, the underlying neu-	 R G, Provencio I, Hudson D, Fiske S, DeGrip W, Menaker M
roanatomy and neurophysiology which mediate vision have 60 (1991) Circadian photoreception in the retinally degenerate
been studied extensively over the past two centuries. More 	 mouse (rd/rd). J Comp Physiol [A] 169:39-50; Freedman M
recently, the retinohypothalamic tract (RHT), a distinct neu- 	 S, Lucas R J, Soni B, von Schantz M, Munoz M, David-Gray
ral pathway which mediates circadian regulation by environ-	 Z, Foster R G (1999) Regulation of mammalian circadian
mental light, has been shown to project from the retina to the 	 behavior by non-rod, non-cone, ocular photoreceptors. Sci-
suprachiasmatic nuclei (SCN) in the hypothalamus. (Moore 65 ence 284:502-504). Studies using rodents with retinal degen-
R Y, Lenn N J. A retinohypothalamic projection in the rat. J	 eration suggest that neither the rods nor cones used for vision
Comp Neurol 146:1-14, 1972; Moore R Y (1983) Organiza- 	 participate in light-induced melatonin suppression, circadian
US 7,678,140 B2
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phase-shifts, or photoperiodic responses (Pevet et al., 1984; 	 of a specific photoreceptor system for melatonin regulation in
Webb et al., 1985; Foster et al., 1991). Furthermore, enucle- 	 humans with healthy, intact eyes.
ation of rod-less, cone-less transgenic mice abolishes light- 	 Developing an action spectrum is a fundamental means for
induced circadian phase-shifts and melatonin suppression 	 determining the input physiology for the circadian system.
(Lucas and Foster, 1999; Freedman et al., 1999). Recently, 5 This photobiological technique has highutility for 1) defining
light-induced melatonin suppression and circadian entrain-	 the relative effectiveness of photons at different wavelengths
ment have been demonstrated in humans with complete 	 for eliciting a biological response, and 2) identifying the
visual blindness (Czeisler C A, Shanahan T L, Klerman E B,	 specific photopigment involved in that response. (Lipson,
Martens H, Brotman D J, Emens J S, Klein T, Rizzo J F, III 	 1994; Coohill, 1999). The specific aim of the present study
(1995) Suppression of melatonin secretion in some blind io was to characterize the wavelength sensitivity of the photo-
patients by exposure to bright light. N Engl J Med 332:6-11) 	 receptor system responsible for providing circadian input to
and with specific color vision deficiencies. (Ruberg, 1996). 	 the humanpineal glandby establishing an action spectrum for
The study on humans with color vision deficiencies showed
	
light-induced melatonin suppression. The experiments
that protanopic and deuteranopic subjects who lacked func- 	 defined an action spectrum that fits a retinaldehyde opsin
tioning long wavelength-sensitive cones (red, or L cones), 15 template and identified 446-477 nm as the most potent wave-
and middle wavelength cone photoreceptors (green, or M 	 length region for regulating melatonin. Univariance among
cones), exhibited normal light-induced melatonin suppres- 	 the eight fluence-response curves suggests that a single pho-
sion and entrainment of the melatonin rhythm (Ruberg F L, 	 topigment is primarily responsible for melatonin suppres-
Skene D J, Hanifin J P, Rollag M D, English J, Arendt J, 	 sion. These results suggest that there is a novel photopigment
Brainard G C (1996) Melatonin regulation in humans with 20 in the human eye which mediates circadian photoreception.
color vision deficiencies. J Clin Endocrinol Metab 81:2980- 	 Light as a Therapeutic Stimulus
2985). Thus, by themselves, neither the red nor green cone 	 Numerous studies have shown that environmental light is
system could be the primary input for melatonin regulation, at 	 the primary stimulus for regulating circadian rhythms, sea-
least in humans with color vision deficiencies. Together, the	 sonal cycles, and neuroendocrine responses in many mam-
results from human and animal circadian studies on different 25 malian species including humans (Klein et al., 1991; Morin,
forms of visual blindness suggest that melatonin regulation	 1994; Czeisler, 1995). During the past 20 years, studies have
by light is controlled, at least in part, by photoreceptors which 	 tested the use of light for treating fall and winter depression
differ from the photoreceptors that mediate vision. 	 (Seasonal Affective Disorder or SAD), nonseasonal depres-
Recent studies with various vertebrate species have iden- 	 sion, sleep disorders, menstrual dysfunction, and eating dis-
tified several new molecules which may serve as circadian 30 orders. In addition, investigators are exploring the use of light
photopigments. These putative photopigments include both
	
for re-entraining human circadian physiology relative to the
opsin-based molecules, such as vertebrate ancient (VA) opsin 	 challenge of shift work or intercontinental air travel. A Con-
and melanopsin, as well as non-opsin molecules like the 	 gressional report estimated that there are 20 million shift
cryptochromes (Soni B G, Foster R G (1997) A novel and 	 workers in the United States. (US Congress, 1991). The two
ancient vertebrate opsin. FEBS Lett 406:279-283; Provencio 35 most common problems associated with shift work are
I, Jiang G, De Grip W J, Hayes W P, Rollag M D (1998)	 reduced alertness on the job and reduced sleep quality after
Melanopsin: an opsin in melanophores, brain, and eye. Proc 	 work. In addition, shift workers have increased health prob-
Natl Acad Sci U S A 95:340-345; Miyamoto Y, Sancar A 	 lems including higher risk of cardiovascular disease and gas-
(1998) Vitamin 132-based blue-light photoreceptors in the 	 trointestinal distress as well as cognitive and emotional prob-
retinohypothalamic tract as the photoactive pigments for set-  40 lems. Chronic desynchronization of the circadian system is
ting the circadian clock in mammals. Proc Natl Acad Sci U S	 cited as one of the causes for these problems. (US Congress,
A 95:6097-6102). Among these new photopigments, only 	 1991).
melanopsin has been specifically localized to the human	 Light is known to be a potent stimulus for entraining and
retina. (Provencio I, Rodriguez I R, Jiang G, Hayes W P, 	 phase-shifting circadian rhythms in many species, including
Moreira E F, Rollag M D (2000) A novel human opsin in the 45 humans. (Czeisler et al., 1986; Klein et al., 1991). The circa-
inner retina. J Neurosci 20:600-605). The molecular identifi- 	 dian response to light is dependent on the stimulus intensity,
cation of these candidate photopigments and their localiza- 	 wavelength and time of delivery. A phase-response curve
tion in the retina and/or neural components of the circadian 	 (PRC) describes light-induced shifts inrhythms relative to the
system make them well-suited to act as circadian phototrans- 	 circadian phase when the light is given, and PRCs to light
ducers. Functional data confirming their direct role in circa- 50 share similarities across many species.
dian photoreception, however, have been lacking. 	 Working from the human PRC to light, some investigators
The present invention required determining whether or not 	 have tested strategies of light treatment to improve circadian
the three cone system, which supports photopic (daytime) 	 entrainment thereby enhancing performance, alertness, and
vision, was also the primary input for pineal melatonin sup- 	 health in shift workers. Studying simulated shift work, dif-
pression in humans with normal, healthy eyes. The peak 55 ferent groups of investigators have shown that workers had
wavelength sensitivity of the photopic visual system is near	 accelerated circadian re-entrainment, enhanced alertness,
555 nm. (Rodieck R W (1998) The First Steps in Seeing, 	 and improved sleep quality after treatment with bright light
Sunderland, Mass.: Sinauer Associates, Inc.). If melatonin	 (2,000 lux to 12,000 lux) versus dimmer light (10 lux to 150
regulation were mediated primarily by the three cone photo- 	 lux).
pic visual system, then 555 nm light would be the most potent 60	 Light Stimulation of the Circadian and Neuroendocrine
wavelength for regulating melatonin secretion. 	 Systems
In the present invention, data show that 505 nm is approxi- 	 Over the last two centuries, extensive research has eluci-
mately four times stronger than 555 nm in suppressing mela- 	 dated the neuroanatomy and neurophysiology which support
tonin. These results demonstrate that the ocular photoreceptor 	 the sensory capacity of vision in mammals. More recently,
primarily responsible for pineal melatonin regulation in 65 animal studies have demonstrated a neural pathway, named
humans, is not the cone system that is believed to mediate 	 the retinohypothalamic tract (RHT), which projects from the
photopic vision. This present invention involved the first test	 retina into the hypothalamus. (Moore and Lenn, 1972; Klein
US 7,678,140 B2
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et al., 1991). Information about light is transmitted from the
retina to the hypothalamic suprachiasmatic nuclei (SCN)
which are fundamental circadian oscillators that regulate
daily rhythms. (Klein et al., 1991). The pathways supporting
vision and circadian regulation are anatomically separate, but 5
there may be a link between these systems by a projection
from the intergeniculate leaflet to the SCN. (Morin, 1994).
Although the detailed neuroanatomy of the circadian system
primarily has been determined with animal studies, parallel
clinical and post-mortem studies suggest that humans have a io
similar circadian neuroanatomy. (Schwartz et al., 1986).
The circadian system controls daily rhythms of sleep,
wakefulness, body temperature, hormonal secretion, and
other physiological parameters. (Klein et al., 1991; Morin,
1994; Lam, 1998). There is considerable evidence from stud- 15
ies on mammals that the circadian and neuroendocrine effects
of light are mediated via photoreceptive physiology in the eye
as opposed to photoreceptive physiology in the skin or some
other part of the body. A study by Campbell and Murphy
(1998), however, reported that a 3 hour bright light pulse of 20
13,000 lux delivered to the backs of the knees of human
subjects systematically reset circadian rhythms of body tem-
perature and melatonin. In contrast, two recent studies failed
to elicit acute melatonin suppression with similar bright light
exposure to the backs of the knees in healthy humans and an 25
attempt to replicate Campbell and Murphey's findings failed
to demonstrate a phase-shift after light exposure to the back of
the. Further work is needed to determine whether or not the
eyes are the exclusive sites for circadian photoreception in
humans and other mammalian species. Data suggest that the 30
eyes are the primary (if not exclusive) site for circadian and
neuroendocrine phototransduction. Although light is the prin-
cipal stimulus for regulating the circadian system, other exter-
nal stimuli such as sound, temperature, social cues and con-
ditioning may also influence physiological timing functions. 35
Light Regulation of Melatonin
A well-defined neural pathway carries photic information
about light extends from the SCN to the pineal gland via a
multisynaptic pathway with connections being made sequen-
tially in the paraventricular hypothalamus, the upper thoracic 40
intermediolateral cell column, and the superior cervical gan-
glion. (Moore, 1983). By way of this neuroanatomy, cycles of
light and dark which are perceived through the eyes entrain
SCN neural activity which, in turn, entrains the rhythmic
synthesis and secretion of melatonin from the pineal gland. In 45
virtually all species including humans, high levels of melato-
nin are secreted during the night and low levels are secreted
during the day.
In addition to entraining the melatonin circadian rhythm,
light can acutely suppress melatonin secretion. Specifically, 50
exposure of the eyes to light during the night causes a rapid
decrease in the high activity of the pineal enzyme serotonin-
N-acetyltransferase and subsequent inhibition of synthesis
and secretion of melatonin. The acute light-induced suppres-
sion of melatonin was first observed in rats and later in 55
humans (Klein and Weller, 1972; Lewy et al., 1980). This
response has been used as a tool by the PI (GCB) and many
other investigators to help determine the ocular, neural and
biochemical physiology for melatonin regulation. (Klein et
al., 1991; Brainard et al., 1997). In addition, seasonal changes 60
in photoperiod length alters the duration of the elevated mela-
tonin production. Specifically, in a number of mammalian
species including humans, the duration of increased noctur-
nal melatonin secretion is shorter in the summer due to short-
ened night time periods. In summary, many studies have 65
shown that light stimuli are the strongest and most consistent
regulators of melatonin. In addition, certain drugs can pow-
6
erfully impact melatonin secretion, while other non-photic
and non-pharmacologic stimuli that may modify melatonin
levels include body posture and exercise.
Phototransduction and Action Spectrum Analysis
The overall aim of the present invention is the identification
of the photoreceptor(s) for applications in the areas of circa-
dian regulation, neuroendocrine regulation, and the clinical
benefits of light therapy in humans. Fundamentally, all pho-
tobiological responses are mediated by specific organic mol-
ecules that absorb photons and then undergo physical-chemi-
cal changes which, in turn, lead to broader physiological
changes within the organism. This photobiological process is
termed phototransduction and the organic molecules which
absorb light energy to initiate photobiological responses are
called photopigments. Generally, these photoactive mol-
ecules do not absorb energy equally across the electromag-
netic spectrum. Each photoreceptor molecule or complex has
a characteristic absorption spectrum which depends on its
atomic structure. An action spectrum is one of the main tools
for identifying the photopigment which initiates a photobio-
logical response. The simplest definition of an action spec-
trum is the relative response of an organism to different wave-
lengths. (Lipson, 1994; Coohill, 1999).
Photobiologists have evolved a refined set of practices and
guidelines for determining analytical action spectra which are
applicable to all organisms from plants to humans. (Coohill,
1991; Lipson, 1994). Analytical action spectra are developed
using two or more monochromatic light stimuli with half-
peak bandwidths of 15 nm or less. Generally, these action
spectra are determined by establishing a set of dose-response
curves (fluence-response curves) at different wavelengths for
a specific biological response. The action spectrum is then
formed by plotting the reciprocal of incident photons required
to produce the criterion biological response versus wave-
length. This fundamental photobiological technique has high
utility for 1) defining the relative effectiveness of different
wavelengths for eliciting a biological response, and 2) iden-
tifying the specific photosensitive molecules involved in bio-
logical responses.
Action Spectra for Circadian Regulation in Rodents
As in other fields of photobiology, the initial attempts to
define circadian and neuroendocrine responses to wavelength
began with polychromatic action spectra which tested
broader bandwidths of light in various rodent species (Coo-
hill, 1991). These polychromatic action spectra were pub-
li shed mainly during the early 1970's through the mid 1980's
and were reasonably consistent in indicating that the spectral
region between 450 nm and 550 nm provides the strongest
stimulation of circadian and neuroendocrine responses in
rodents (for review: Brainard et al., 1999). Analytic action
spectra, however, are superior to polychromatic action spec-
tra for identifying the photopigments that mediate photobio-
logical responses.
In a landmark study, Takahashi and colleagues determined
an analytic action spectrum for circadian wheel running
behavior in Syrian hamsters (Takahashi et al., 1984). Their
study established fluence-response functions for a set of
monochromatic wavelengths and then formed an action spec-
trum from those fluence-response functions. Their action
spectrum had a spectral peak (,max) around 500 nm and
seemed similar in shape to the absorption spectrum for
rhodopsin. Although they found these data to support the
hypothesis that a rhodopsin-based photopigment and rod
cells in the retina mediate circadian entrainment in hamsters,
they were careful to point out that the participation of a cone
mechanism could not be excluded. Since then, three other
analytic action spectra have been published on circadian and
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neuroendocrine regulation in rodents. (Bronstein et al., 1987;	 Thus, it is premature to rule out the visual photoreceptors
Provencio and Foster, 1995; Yoshimura and Ebihara, 1996). 	 from playing a role in circadian regulation in animals with
Data from these action spectra have been fitted to spectral 	 normal, intact eyes.
sensitivity curves for retinal-based visual photopigments. 	 If the rods and cones that mediate vision in rodents are not
This curve fitting is predicated on the assumption that a reti- 5 the primary photoreceptors for circadian regulation in
nal-based molecule transduces light stimuli for circadian	 rodents, what are the alternative candidates? Recent studies
regulation, and allows the prediction of the shape of the	 with various vertebrate species have identified several new
photopigment absorption spectrum as well as its peak sensi- 	 molecules which may serve as circadian photopigments.
tivity (,max). Across these rodent studies, the predicted 	 These putative photopigments include both opsin-based mol-
,max ranges from 480 nm to 511 nm and is surrounded by a io ecules such as vertebrate ancient (VA) opsin (Soni and Foster,
broad region of high sensitivity. From these studies, different 	 1997), melanopsin (Provencio et al., 1998), and peropsin
photopigments have been suggested to be responsible for 	 (Sun et al., 1997) as well as non-opsin molecules like biliver-
circadian regulation including rhodopsin, a rhodopsin-like 	 din (Oren, 1996) and cryptochrome (Miyamoto and Sancar,
molecule, a middle wavelength cone photopigment, or a UV 	 1998). Among these new photopigments, only melanopsin
cone photopigment. Furthermore, preliminary data from 15 has been specifically localized to the human neural retina
other investigators working with Takahashi, showed that the 	 (Provencio et al., 2000) and cryptochrome has been localized
action spectrum for photoperiod-dependent reproductive	 to the mouse neural retina (Miyamoto and Sancar, 1998). The
development response of male Siberian hamsters and light- 	 molecular identification of these candidate photoreceptors
induced phase-shifting of circadian locomotor activity has its	 and their localization in the retina and/or neural components
,max in the range of 475 mu. The investigators interpret their 20 of the circadian system, make them well-suited to act as
unpublished action spectra to support the hypothesis that a 	 circadian phototransducers.
short wavelength-sensitive photoreceptor mediates both 	 In summary, the present invention involves a light system
functions. (Fred Turek, PhD, personal communication). 	 for stimulating or regulating neuroendocrine, circadian, and
Circadian Regulation in Rodents with Loss of Cone and	 photoneural systems in mammals based upon the discovery of
Rod Photoreceptors	 25 peak sensitivity ranging from 425-505 mu. Also, the present
It is important to note that there is considerable diversity in 	 invention involves a light meter system for quantifying light
the cellular structure and function of the retina across mam- 	 which stimulates mammalian circadian, photoneural, and
malian species, and that in rodents the retina contains both	 neuroendocrine systems, wherein the light meter has at least
cone and rod photoreceptors. (Rodieck, 1998). Early studies 	 one light metering device to match peak wavelength sensitiv-
with blind mole rats and rats with destruction of retinal pho-  30 ity of mammalian photoreceptors for mammalian circadian,
toreceptors due to prolonged light exposure raised the possi- 	 photoneural, and neuroendocrine systems. Furthermore, the
bility that neither the rods nor the cones used for vision	 present invention exploits this peak wavelength sensitivity for
participate in regulating the circadian and neuroendocrine	 novel light systems, novel translucent and transparent mate-
systems. (Pevet et al., 1984; Webb et al., 1985). Despite	 rials, and novel lamps or other light sources with or without
profound loss of photoreceptors and vision, light detection for 35 filters. The present invention also involves the peak sensitivity
circadian and photoperiodic regulation was preserved. It 	 as the focal point for treatment of mammals with a wide
remained possible, however, that a small population of sur- 	 variety of disorders or deficits, including but not limited to,
viving rods or cones could still be responsible for circadian 	 light responsive disorders, eating disorders, menstrual cycle
photoreception.	 disorders, non-specific alerting and performance deficit, hor-
Studies in mice with hereditary retinal disorders (rd/rd and 40 move-sensitive cancers, and cardiovascular disorders.
rds/rds) have shown that these animals still exhibit normal
light-induced melatonin suppression and circadian locomo- 	 DEFINITIONS
tor phase-shifts despite a nearly total loss of classical visual
photoreceptors. The data support the conclusion that circa- 	 "Light responsive disorders" means any disorder respond-
dian photoreception is maintained either by 1) a very small 45 ing to or preventable by phototherapy and includes, but is not
number of rod or cone cells, or 2) an unrecognized class of 	 limited to, seasonal affective disorders, sleep disorders, cir-
retinal photoreceptors. (Foster et al., 1991; Provencio et al., 	 cadian disruption, eating disorders, menstrual cycle disor-
1994; Yoshimura et al., 1994). Further work with rd mice	 ders, non-specific alerting or performance deficits, hormone-
suggested that middle-wavelength sensitive (M-cones) and/ 	 sensitive cancers (including, but not limited to, breast
or S-cones may be responsible for circadian photoreception. 50 cancers), and cardiovascular disorders.
(Provencio and Foster, 1995; Yoshimura and Ebihara, 1996).	 "Light system" means a lamp, a lamp with filters, or
Recent studies with transgenic coneless (cl) mice which have 	 another system or source for delivering light.
extensive loss of M-cones and S-cones show that these mice 	 "Translucent or transparent material component" or
exhibit normal sensitivity for light-induced melatonin sup- 	 "translucent or transparent material" includes, but is not lim-
pression and circadian phase-shifting of locomotion. (Lucas 55 ited to, at least one of the following: glasses, visors, windows,
et al., 1999; Freedman et al., 1999). Similarly, coneless, rod-	 contacts, and filters. These materials may shape natural or
less mice (rd/rd cl) also appeared to exhibit normal sensitivity 	 artificial light.
for light-induced melatonin suppression and phase-shifting	 "Light source" includes, but is not limited to, at least one of
of wheel-running behavior. These results indicate that rods, 	 the following light sources: artificial light, natural light, and
M-cones and S-cones are not required for circadian photore- 60 lamps.
ception. Removal of the eyes however, abolished light-in-
duced circadian phase-shifting. (Freedman et al., 1999). 	 SUMMARY OF THE INVENTION
Overall the results suggest that the mouse eye contains spe-
cific photoreceptors for circadian regulation different from	 The present invention involves a light system for stimulat-
the visual photoreceptors. A study on normal rats, however, 65 ing or regulating neuroendocrine, circadian, and photoneural
shows that the rod and cone photoreceptors for vision provide	 systems in mammals based upon the discovery of peak sen-
input to SCN neurons. (Aggelopoulos and Meissl, 2000). 	 sitivity ranging from 425-505 mu. Also, the present invention
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involves a light meter system for quantifying light which
stimulates mammalian circadian, photoneural, and neuroen-
docrine systems, wherein the light meter has at least one light
metering device to match peak wavelength sensitivity of
mammalian photoreceptors for mammalian circadian, photo- 5
neural, and neuroendocrine systems, said peak wavelength
ranging between 425-505 mu. Furthermore, the present
invention exploits this peak wavelength sensitivity for novel
light systems, novel translucent and transparent materials,
and novel lamps or other light sources with or without filters. io
The present invention also involves exploiting this peak sen-
sitivity for treatment of mammals with a wide variety of light
responsive disorders or deficits, including but not limited to,
light responsive disorders, eating disorders, menstrual cycle
disorders, non-specific alerting and performance deficit, hor- 15
mone-sensitive cancers, and cardiovascular disorders.
The light metering device is specifically configured to
accurately quantify electromagnetic radiation that stimulates
or regulates the circadian, photoneural, and neuroendocrine
systems of healthy mammals or mammals having a variety of 20
disorders. The meter's wavelength sensitivity matches the
wavelength sensitivity of the photoreceptors for circadian,
photoneural, and neuroendocrine regulation in mammals.
This device is also used to quantify electromagnetic radiation
which is optimum for treating Seasonal Affective Disorders 25
(SAD) or other light-responsive disorders.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1: In this graph the bars represent group mean+SEM 30
plasma melatonin values (N=8) before and after monochro-
matic light exposure at 505 nm. There were no significant
variations across mean melatonin pre-light exposure values
(F-0.85). Paired, two-tailed Students' t tests demonstrated
which light intensities elicited a significant melatonin sup-  35
pression.
FIG. 2: This graph illustrates group mean+SEM % control-
adjusted melatonin change values (N=8) at 505 nm mono-
chromatic light exposure. The figure shows that progressively
higher light irradiance exposure produces increasingly 40
greater melatonin suppression.
FIG. 3: This figure demonstrates the fitted fluence-re-
sponse curve for photon density and % control-adjusted
melatonin suppression (N=8). Each data point represents one
group mean±SEM.	 45
FIG. 4: The bars represent group mean+SEM values rela-
tive to an equal photon dose of 4.2x10 13 photons/cm2 . These
data show that the 505 nm % control-adjusted plasma mela-
tonin suppression is significantly stronger than that for 555
run.
FIG. 5: This diagram illustrates the experimental elec-
tronic, optic and ganzfeld dome exposure array. This appara-
tus provides a uniform, patternless stimulus that encompasses
the subject's entire visual field. For clarity, the subject's head
is shown slightly withdrawn from the opening of the ganzfeld
dome. During all light exposures, the subjects' bony orbits are
completely enclosed in the dome walls providing complete
exposure of their visual fields.
FIG. 6: In this graph the bars represent group mean+SEM
plasma melatonin values before and after monochromatic
light exposure at 460 nm in eight healthy subjects. There were
no significant differences (F-0.70, p-0.69) across pre-expo-
sure mean melatonin values. Light irradiances at or above 3.1
µW/cm2 elicited significant melatonin suppression.
FIG. 7: This figure illustrates the mean+SEM plasma mela-
tonin percent control-adjusted change scores from eight
healthy subjects exposed to different irradiances of mono-
10
chromatic light at 460 mu. Progressively higher irradiance
exposures at 460 nm produce progressively greater plasma
melatonin percent control-adjusted change scores
(p<0.0001).
FIG. 8: This graph demonstrates the best fit fluence-re-
sponse curve for 460 mn exposures and percent control-
adjusted melatonin suppression (R 2-0.97). Each data point
represents one group mean±SEM from eight healthy sub-
jects.
FIG. 9: This figure illustrates the fitted univariant fluence-
response curves for monochromatic light exposures and per-
cent control-adjusted melatonin suppression for eight wave-
lengths of visible light. Each fluence-response curve is
derived from eight healthy volunteers who participated in a
complete, within-subjects experimental design. In each
graph, the data points represent group means±SEM. Each
curve has a high coefficient of correlation (0.95 to 0.81).
FIG. 10: In this graph the bars represent group mean+SEM
plasma melatonin values before and after exposure to 31.8
µW/cm2 monochromatic light at 420 nm in eight healthy
subjects. This light irradiance induced a significant melatonin
suppression (p<0.003).
FIG. 11: This graph demonstrates the action spectrum for
percent control-adjusted melatonin suppression in 72 healthy
human subjects. The filled circles represent the half-satura-
tion constants of eight wavelengths from 440 to 600 mn
which were normalized to the maximum response and plotted
as log relative sensitivity. The open circle represents the esti-
mated half-saturation constant derived from the 420 mn data.
The line in the graph portrays the best fit template for vitamin
A, retinaldehyde photopigments which predicts a maximal
spectral absorbance (1 max) of 464 nm (Partridge and De
Grip, 1991). There is a high coefficient of correlation for
fitting this opsin template to the melatonin suppression data
(R2-0.91). The basis for the balanced wavelength peak sen-
sitivity range is a calculation of approximately two standard
deviations from 464 nm.
FIG. 12: This figure illustrates a comparison of the mela-
tonin suppression and visual action spectra. The maximal
spectral response and long wavelength limb of the melatonin
suppression template is plotted along with the maximal spec-
tral response and long wavelength limbs of the human rods
and cones that support vision (Stockman and Sharpe, 1999).
The shaded area around the 464 nm template represents±SD
from the data presented above.
DETAILED DESCRIPTION
The science of photobiology involves the study of how the
50 infrared, visible and ultraviolet portions of the electromag-
netic spectrum influence biological processes. There are two
broad categories of light measurement techniques: radiomet-
ric and photometric. Each measurement technique has its
merits and drawbacks relative to circadian regulation, neu-
55 roendocrine regulation and light therapy. Radiometry is based
exclusively on the physical properties of light its energy
and wavelength. A radiometer measures the radiant power of
a light source over a defined range of wavelengths. Radiom-
eters can be configured to measure different bandwidths
6o across the electromagnetic spectrum. The wavelengths within
the designated bandwidth can be detected equally, or they can
be filtered for differential sensitivity across the various wave-
lengths.
In contrast to radiometry, photometry is based on the selec-
65 tive responsiveness of the human visual system. A photom-
eter is simply a radiometer that has filters added to the detec-
tor which "shape" the detector sensitivity to resemble the
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luminance (brightness) response of the human visual system.
Thus, photometry is a special branch of radiometry. Between
individual humans, there are substantial differences in visual
responses. The average photopic and scotopic visual func-
tions are defined with reference to the adaptive state of the rod
and cone photoreceptors in the human retina. Radiometers
can be filtered to detect only those relative proportions of
wavelengths that comprise the photopic or scotopic visual
response. Photometers will detect photopic lux or scotopic
lux, respectively. Specifically defined, lux measures are mea-
sures of illuminance the amount of light, or luminous flux,
falling on a surface. One photopic lux is one lumen per square
meter (1 m/m2). The new metering system is configured to
measure a new lighting unit which could be called "circadian
lux" as opposed to photopic lux or scotopic lux.
Most investigators have operated from the assumption that
light therapy is mediated via a photoreceptive mechanism in
the human eye as opposed to a photoreceptive mechanism in
the skin or some other part of the body. The data of the present
invention demonstrate that the photoreceptive mechanism for
the circadian and neuroendocrine system or the photorecep-
tive mechanism that mediates light therapy is not identical to
the photoreceptive system that mediates the sensory capacity
of vision.
Subjects, Materials and Methods
Subjects
The healthy females (N=6) and males (N=10) in this study
had a mean±SEM age of 25.7±0.8 yrs, demonstrated normal
color vision as measured by the Ishihara and Farnsworth
Munsell D-100 tests (mean FM score: 64 .2±11.5), had a
stable sleeping pattern (mean wake-up time 7:30 AM±12
min), and signed an approved IRB consent document before
participating.
Light Exposure Protocol
Each experiment began at midnight when subjects entered
a dimly lit room (10 lux). One drop of 0.5% Cyclopentolate
HCl was placed in each eye to dilate the pupils, andblindfolds
were placed over subjects 'eyes. Subjects remained sitting
upright in darkness for 120 min. While still blindfolded and
justprior to 2:00 AM, a blood sample was taken by venipunc-
ture. During light exposure, each subject ' s head rested in an
ophthalmologic head holder facing a Ganzfeld apparatus that
provided a concave, patternless, white reflecting surface
encompassing the subject's entire visual field. The subjects
were exposed to the light stimulus from 2:00 to 3:30 AM.
During this 90 min exposure, subjects sat quietly, kept their
eyes open and gazed at a fixed target dot in the center of the
Ganzfeld dome. Subject compliance for keeping their eyes
open and the subjects' pupil size were monitored by a min-
iature video camera. At 3:30 AM, a second blood sample was
taken. Each subject was exposed to complete darkness from
2:00 to 3:30 AM on their control night and was tested with at
least 6 days between each nighttime exposure. Plasma
samples were assayed for melatonin by RIA. (Rollag, 1976).
The minimum detection limit of the assay was 0.5-2.0 pg/mL.
Control samples had 8% and 14% intra-assay coefficients of
variation.
Light Production and Measurement
Experimental light stimuli were produced by xenon arc
lamps (Photon Technology Int'l, Inc., Princeton, N.7.)
enclosed in a light-proof chamber and cooled by high-speed
fans and water circulation. An exit beam of light from each
source was directed by a parabolic reflector, and excess heat
in this beam was reduced by a water filter. Monochromatic
wavelengths (10-11 nm half-peak bandwidth) were produced
by a grating monochromator and light irradiance was con-
trolled by a manual diaphragm. The resulting light beam was
12
directed into the top area of a Ganzfeld dome and reflected
evenly off the walls into volunteers' eyes. The entire reflect-
ing surface of the dome was coated with a white surface with
a 95-99% reflectance efficiency over the 400 to 760 nm range.
5 Routine measurement of the light irradiance (µW/cm2) was
done with a 716 Meter with a 76512 irradiance probe (Tek-
tronix, Beaverton, Oreg.). Experimental light stimuli
reflected from the Ganzfeld domes were measured at volun-
teers' eye level immediately before and after the 90 min
io exposure. Additional measures were taken each half hour of
the exposure to insure stimulus stability and enable intensity
readjustment. Subjects in the 505 nm series were exposed to
intensities ranging from 0.011 to 97 ltW/cm2 (a 3 log unit
photon density range of 10 10 to 1013 photons/cm2). Subjects
15 exposedto 555 mn received control or  15 ltW/cm 2 (4.2x1013
photons/cm2) exposure.
Statistics
Two-tailed, Students' t tests were used to assess signifi-
cance of raw melatonin change from 2:00 to 3:30 AM. These
20 data were then converted to % control-adjusted melatonin
change scores as described elsewhere. (Gaddy, 1993). For the
505 nm data, sets of pre-exposure melatonin values and %
control-adjusted melatonin change scores were analyzed with
one-way, repeated measures ANOVA. Significant differences
25 between groups were assessed with post-hoc Scheffe F-tests;
alpha was set at 0.05. For the 505 nm mean % control-
adjusted melatonin suppression data, the computer program
Origin 6.0 (Microcal, Northampton, Mass.) was used to fit a
fluence-response curve to a 4 parameter model as described
so elsewhere (Brainard, 19893), andto test forgoodness -of-fitof
the data by coefficient of correlation.
Results
The full 505 nm data complement, from raw melatonin
35 values to a final fluence-response curve, is illustrated in FIGS.
1-3. Across all nights of testing, there were no significant
differences (F-0.85) between sets of pre-exposure melatonin
values indicating that plasma levels were consistent across
the different study nights. FIG. 1 shows the mean±SEM pre-
40 and post-exposure melatonin values. One-way, repeated mea-
sures ANOVA showed a significant effect of light intensity on
plasma melatonin % change scores (F=17.17, P<0.0001).
Paired t tests demonstrated that compared to the 0 µW/cm2
control night, all intensities at or above 5.5 µW/cm2 signifi-
45 cantly suppressed melatonin (P<0.05 or less). In contrast,
irradiances of 2.8, 1.4 and 0.011 µW /cm2 did not suppress
melatonin compared to the control night (Scheffe F values:
0.97, 0.01 and 0.02, respectively). As illustrated in FIG. 2, all
melatonin data were converted to control -adjusted % change
50 scores. As with the melatonin % change scores, ANOVA
showed a significant effect of light intensity on plasma mela-
tonin % control-adjusted change scores (F=13.59,
P<0.0001). FIG. 3 illustrates a best fit, sigmoidal fluence-
response curve which plots melatonin % control-adjusted
55 scores against stimulus photon density. The specific formula
for this curve is included in the figure.
Subjects exposed to 555 mn received both control (0
µW/cm2) and 15 µW/cm2 (4.2x10 13 photons/cm2) exposures.
For the control and light exposure nights, the mean pre-
60 exposure raw melatonin scores were 64.4±12 . 5 and 59.6±6.2,
while the mean post-exposure scores were 62.6±10.5 and
49.1 ±6.0, respectively. The modest drop in melatonin over the
90 min 555 nm light exposure period was not statistically
significant (t=1.69, df^=7, P-0.14). For comparison of
65 responses to 505 nm and 555 mu, FIG. 4 illustrates % control-
adjusted melatonin suppression relative at equal photon den-
sities across the two wavelengths. These data reveal that 505
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mn is significantly stronger than 555 mn in suppressing mela- 	 and 600 mu. A within-subjects design was used for each
tonin (t=3.04, df^=14, P<0.01).	 fluence-response curve. For each wavelength studied, a set of
Discussion	 8 volunteers was exposed to a minimum of 8 different light
The data presented here demonstrate that: 1) there is a clear 	 irradiances on separate nights with at least 6 days between
fluence-response relationship between graded light intensi-  5 exposures. At the completion of that work, it was determined
ties of 505 nm light and melatonin suppression, and 2) that 	 that a probe of sensitivity to monochromatic light below 440
505 mn light is significantly stronger than 555 nm light for 	 mn was needed. Consequently, a group of 8 subjects was
suppressing melatonin in healthy, human subjects. Previous 	 exposed to a single night of no light exposure and a single
studies with animals and humans have illustrated fluence- 	 night of exposure to one irradiance of 420 mn light.
response relationships for melatonin suppression and circa-  10	 Subjects
dian phase-shifting with exposure to monochromatic light	 Volunteers who were involved in shift work, planned long
(Podolin, 1987; Brainard, 1988; Nelson, 1991) as well as 	 distance jet travel before or during the study period, or had
white light (Brainard, 1983; Boivin, 1996). A recent study on	 irregular sleeping schedules were excluded from this study.
human subjects suggests that a four parameter curve is opti-	 The subject drop-out rate was 7.9%. The ethnic distribution of
mal for modeling light-induced melatonin suppression and 15 the 72 subjects who completed this study included 55 Cau-
circadian phase shifting. (Zeitzer, 1997). That contention 	 casians, 9 Asians, 4 African Americans, 3 Hispanics and 1
matches earlier animal data (Brainard, 1983) as well as the 	 individual of unknown ethnicity. Subjects who had a rela-
505 nm data reported here.	 tively stable daily sleeping pattern, passed a physical exam
The demonstration that 505 mn light is more potent than	 for general and ocular health, and signed an approved IRB
555 mn light for controlling melatonin has important basic 20 consent document were accepted into this study. A total of 37
science and clinical implications. In humans, it is well-estab- 	 females and 35 males between 18-30 years old (mean±SEM
lished that higher levels of ocular illumination are required 	 age=24.5±0.3) completed the study. The self-reported
for stimulating the circadian system than for supporting	 mean±SE weekday wake-up time among subjects was 7:06
vision. (Lewy, 1980, Nelson, 1991; Czeisler, 1986). Conse- 	 AM±18 min. All subjects were normal on the Ishihara and
quently, many investigators have considered the three cone 25 Farnsworth MunsellD-100 tests for color vision(mean±SEM
photopic visual system to be responsible for stimulating cir- 	 FM score: 51.4±4.3).
cadian and neuroendocrine responses since this part of the 	 Light Exposure Protocol for Action Spectra
visual system is responsive to "bright" daytime levels of 	 Each experiment began at midnight when subjects entered
illumination. Over the past 20 years most of the published 	 a dimly lit room (10 lux or less). One drop of 0.5% Cyclo-
literature on human circadian responses to light reports light 30 pentolate HCl was placed in each eye to dilate the subjects'
levels in terms of illuminance (lux, lumens) which is a spe- 	 pupils and blindfolds were placed over their eyes. Subjects
cific measure based on the traditional sensitivity curve of the 	 remained sitting upright for 120 minutes and listened to
photopic visual system. The peak wavelength sensitivity of 	 music on headphones or engaged in quiet conversation. While
that curve is 555 mu. (Rodieck, 1998). Indeed, some research- 	 still blindfolded and just prior to 2:00 AM, a 10 ml blood
ers have argued that their data support the notion that the 35 sample was taken by venipuncture of the antecubital vein.
visual cones are involved in circadian phase-shifting in 	 Subjects' blindfolds were then removed and the subjects were
humans. (Zeitzer, 1997). If melatonin regulation is mediated 	 exposed to the monochromatic light stimulus from 2:00 to
primarily by the three cone photopic visual system, then 555 	 3:30 AM. During light exposure, each subject's head rested in
mn light should be the most potent wavelength for regulating 	 an ophthalmologic head holder facing a ganzfeld apparatus
melatonin. The data here do not support this view. On the 40 thatprovided a concave, patternless reflecting surface encom-
contrary, 505 mn is significantly stronger, photon for photon, 	 passing each subject's entire visual field (see FIG. 1). During
than 555 mn in suppressing melatonin. The clinical implica-	 this 90 minute exposure, subjects sat quietly, kept their eyes
tion of this result is that it is not optimum to use photometric	 open and gazed at a fixed target dot in the center of the
values (lux) for quantifying light used therapeutically in 	 ganzfeld dome. Subject compliance for keeping their eyes
patients with certain sleep disorders or circadian disruption 45 open and the subjects' pupil size were monitored by a min-
due to shiftwork or intercontinental jet travel as is the current	 iature video camera inside the ganzfeld dome. If the subjects
standard practice. (1995 Special Issue, 7 Biol).	 began to close their eyes during the exposure period, the
Ultimately, these studies open the door for redefining how 	 experimenters reminded them to keep their eyes completely
light should be measured relative to the circadian system. The 	 open. At 3:30 AM, a second 10 ml blood sample was taken by
best circadian measurement system would match the action 50 venipuncture and the subjects were then permitted to leave
spectrum for human circadian regulation. That action spec- 	 the laboratory. Eight wavelengths were studied for this action
trum would not only elucidate the relative circadian potencies 	 spectrum (440, 460, 480, 505, 530, 555, 575 and 600 mu).
of different wavelengths, but it should help identify the pho- 	 Across these wavelengths, each subject was exposed to com-
toreceptor that initiates signals from the retina to the SCN. 	 plete darkness from 2:00 to 3:30 AM on their control night
In summary, monochromatic 505 mn light suppressed 55 and to a set of irradiances covering a 4 log unit photon density
melatonin in a fluence-response manner, and is approxi- 	 range of 10 10 to 1014 photons/cm2 on exposure nights. For the
mately four times stronger than a 555 mn stimulus at an equal 	 probe of sensitivity to monochromatic light at 420 mu, a
photon dose for melatonin suppression. These data demon-	 group of 8 subjects were exposed to a single night of no light
strate that the three cone system that is believed to mediate 	 exposure and a single night of exposure to 420 nm light at
human photopic vision is not the primary photoreceptor sys-  60 31.8 µW/cm2 (5.58x10 13 photons/cm2).
tem to transduce light stimuli for melatonin regulation. 	 Light Production and Measurement
Action Spectra Study design	 As shown in FIG. 5, experimental light stimuli were pro-
Action spectra are determined by comparing the number of
	
duced by a 450 or 1200 W xenon arc lamp (Photon Technol-
photons required for the same biological effect at different 	 ogy Inc., Princeton, N.7.). Each lamp was enclosed in a light
wavelengths (Lipson, 1994; Coohill, 1999). The melatonin 65 proof chamber and cooled by water circulation. An exit beam
suppression action spectrum described here was formed from 	 of light from each source was directed by a parabolic reflector
fluence-response curves at 8 wavelengths between 440 mn 	 and, for the 1200 W lamps, excess heat in the light beam was
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reduced by a water filter. Monochromatic wavelengths (10-
14.5 mu half-peak bandwidths) were produced by a grating
monochromator and light irradiance was controlled by a
manual diaphragm. The resulting light beam was directed
into the top area of a ganzfeld apparatus and reflected evenly 5
off the walls of the ganzfeld dome into volunteers' eyes. The
entire reflecting surface of the dome was coated with a white
material (Spectralite) with a 95-99% reflectance efficiency
over the 400 to 760 mu range. Routine measurement of the
light irradiance (µW/cm2) was done with a Tektronix 716 to
Radiometer/Photometer with a J6512 irradiance probe (Tek-
tronix, Beaverton, Oreg.). Experimental light stimuli
reflected from the ganzfeld dome was measured at volun-
teers' eye level immediately before and after the 90 minute
exposure. Additional measures were taken each half hour of 15
the exposure to insure stimulus stability and enable readjust-
ment of the intensity if it varied. These spot measures were
taken with a ft-l' meter (Minolta, Osaka, Japan). Spectrora-
diometric assessment of the monochromatic wavelengths at
the level of subjects' corneas was done with a portable spec- 20
troradiometer with a fiber optic sensor (Ocean Optics S2000).
This equipment was calibrated with a standard lamp traceable
to the National Institute of Standards and Technology (NIST).
In action spectroscopy, it is critical that the measured light
stimuli are representative of the stimuli which actually reach 25
the photoreceptors that mediate the photobiological response.
In studies on light regulation of the circadian system, factors
which can modify the measured stimulus before it reaches the
photoreceptors include head and eye motion, squinting and
eye closure, pupillary reflexes, and light transduction through 30
the ocular media (Gaddy et al., 1993; Brainard et al., 1997).
Most of these factors are controlled in the experimental tech-
nique described above. Concerning light transmission
through ocular media, the cornea and aqueous and vitreous
humors normally transmit nearly 100% of visible wave- 35
lengths to the retina and do not change substantively as the
eyes age (Boettner and Wolter, 1962). In contrast, the aging
human lens develops pigmentation that attenuates the trans-
mission of shorter visible wavelengths to the retina (Lerman,
1987; Brainard et al., 1997). In the present study, restricting 40
the age of volunteers to 18-30 years controlled this factor.
Measurements of mean transmittance of 36 postmortem
human lenses in this age range showed relatively even trans-
mission from 440 to 600 mu. In contrast, there was a mean
45% reduction in lens transmission at 420 mu compared to 45
460 mu (Brainard et al., 1997). Consequently, measured cor-
neal light irradiances at 420 nm had to be adjusted to com-
pensate for reduced stimulus transmission to the retina even
in this relatively young study group.
Blood Samples and Melatonin Assay 	 50
Blood samples were collected in glass vacutainers which
contained EDTA. Plasma was separated by refrigerated cen-
trifugation, aliquoted into cryogenic vials and stored at —20°
C. until assay. Melatonin concentrations were assayed by
radioimmunoassay using antiserum described by Rollag and 55
Niswender, (1976). Radiolabeled ligand was prepared by
adding 10 µl of a dioxane solution containing 1 µmole
5-methoxytryptamine and 1 µmole tri-N-butylamine to 250
lLCi (0.1 muole) dried Bolton-Hunter Reagent (New England
Nuclear Corp., Boston, Mass.). The reaction was allowed to 60
proceed for one hour before adding 50 µl of aqueous sucrose
(16 gm/ml electrophoresis buffer) and purifying product by
disc gel electrophoresis. Duplicate aliquots of 200 µl of each
unknown and control sample were extracted into 2 ml of
chloroform. The chloroform was removed in a SpeedVac 65
centrifuge (Savant Instruments, Holbrook, N.Y.) and resus-
pended in 200 µl of assay buffer (phosphate buffered saline,
16
pH 7.4, containing 0.1 % gelatin with 100 mg thimerosal/liter
as a preservative). The extracts were washed twice with 3 ml
of petroleum ether, then evaporated to dryness in a SpeedVac
before being resuspended in 200 µl of deionized water.
Approximately 50,000 cpm of radiolabeled ligand and a
1:256,000 dilution of antiserum (R1055, 9/16/74) was added
to each unknown and a triplicate 2-fold geometric series of
standards ranging in concentration from 0.201 to 200 pg per
200 µl assay buffer. The final assay volume of buffer in each
tube was 400 µl. At the end of the 48 hour incubation period,
three ml of 95% ethanol (4° C.) was added to each assay tube
and the bound radioactivity precipitated by centrifugation at
2000x g for 30 minutes. The supernatant was decanted and
radioactivity in the precipitate was quantified. The quantity of
melatonin immunoreactivity in the samples was calculated
with the use of a computer program (M. L. Jaffe and Associ-
ates, Silver Spring, Md.; see Davis et al., 1980). All solutions
were maintained at 4° C. throughout the radioimmunoassay
procedure. Assay results were not corrected for recovery
(which has proven to be >95% in independent trials). The
minimum detection limit of the assay is 0.5-2.0 pg/ml.
Statistics for Action Spectra
Two-tailed, paired Student's t tests were used to assess
statistical significance of raw melatonin change from 2:00 to
3:30 AM. Percent melatonin change scores were determined
by the following formula:
Percent Melatonin Change Score =
03:30 h melatonin— 02:00 h melatonin
100 x
02:00 h melatonin
Percent melatonin change scores then were normalized to
percent control-adjusted change scores by subtracting the
control (no light) condition percent change scores for each
subject from that same subject's light exposure score. This
technique accounts for the normal individual rise or fall in
plasma melatonin levels with respect to the light-induced
changes (Gaddy et al., 1993; Brainard et al., 1997). For data
from each wavelength, complete sets of pre-exposure mela-
tonin values, percent melatonin change scores, and percent
control-adjusted melatonin change scores were analyzed with
one way, repeated-measures ANOVA. Significant differences
between groups were assessed with post-hoc Scheffe F-tests
with alpha set at 0.05. The group of single fluence-response
curves (one for each wavelength) was fitted to a parametric
model in which the melatonin response (Y) to a photon dose
(X) is predicted by: the theoretical initial Y-response (0 dose)
for the curve (AJ; the theoretical final Y-response ("infinite"
dose) for the curve (Az); the dose producing a response half-
way betweenA, andAz (Xso or EDso); and the slope estimator
(p) for the slope of the curve between A, andA z . The equation
is:
Al —A2
Y 1+(X/X5o)P+A2
The computer program Origin 6.0 (Microcal, Northampton,
Mass.) was used to fit the fluence-response curves to the data.
From extensive experience in our laboratory, a saturating 90
minute light exposure produces a maximum mean percent
control-adjusted plasma melatonin suppression ranging from
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60 to 80% depending on the particular group of subjects being
tested (Gaddy et al., 1993; Ruberg et al., 1996; Wang et al.,
1999; Brainard et al., 2000; 2001). To form an analytical
action spectrum, it is necessary to determine if all fluence-
response curves can be fit to a univariant sigmoidal curve
(Lipson, 1994; Coohill, 1991; 1999). To do this, sigmoid
curves were fitted to the five fluence-response curves between
440 mu and 530 mu which reached a mean percent control-
adjusted melatonin suppression of 60-80% by constraining
the A, factor (theoretical initialY-response) to 0 since no light
exposure should yield a 0% control-adjusted plasma melato-
nin suppression. From this set of curves, a mean A 2 (theoreti-
cal final Y-response or "infinite" dose for the curve), and a
mean p (slope estimator) was calculated. Subsequently, all 8
data sets (including the data sets which did not reach satura-
tion) were then fitted to sigmoid curves that constrained Az
and p to these means and constrainedA, to 0. Each calculated
curve was tested for goodness-of-fit of the data by coefficient
of correlation.
Melatonin Action Spectrum
This action spectrum was formed from the photon density
which elicited the half-saturation constant (ED so) of the per-
cent control-adjusted melatonin suppression for each of the 8
wavelengths. These half-saturation constants were derived
from the 8 univariant fluence-response curves described
above. The half-saturation constants were then normalized to
the maximum response and plotted as relative sensitivity. The
relative quantum sensitivity from each group of subjects was
then graphically plotted (quanta/wavelength) to illustrate the
resultant action spectra for melatonin suppression in humans.
A predicted peak sensitivity for this action spectrum was
determined by fitting a vitamin A,-retinaldehyde photopig-
ment template to the data by a modification of the method
described by MacNichol (1983). Specifically, the long wave-
length limb of vitamin A,-based photopigments can be con-
sidered linear within the 10-90% sensitivity range when plot-
ted on a frequency abscissa. To select the best fit vitamin A,
template, the normalized 10-90% long wavelength melatonin
EDso data were fitted to a series of vitamin A,-based tem-
plates within the 10-90% sensitivity range of the templates'
long-wavelength limbs (Partridge and De Grip, 1991). Pear-
son correlation coefficients derived from fitting the melatonin
data to the templates indicated the optimum fitting template.
Results of Action Spectra
Variations in Pupillary Dilation, Exposure Time and Mela-
tonin Assay
Individuals vary slightly in their pupil size and response to
mydriatic agents. Mean±SD pupillary dilation was 7.19±0.88
mm for all 72 subjects across all nights of exposures. There
were no significant pupil size changes during the light expo-
sures. Similarly, there is a small degree of variability in exact
light exposure durations due to slight experimental delays.
Across 627 single-subject experiments, the mean±SD expo-
sure duration was 90.6±2.1 minutes. A total of 53 assays were
run to quantify melatonin in plasma samples collected during
this project. Coefficients of variation calculated from control
samples assayed as 19.2 pg/ml and 90.0 pg/ml had 10.8% and
4.0% for intra-assay coefficients of variation, respectively.
The inter-assay coefficients of variation were 13.5% and
10.2%.
Fluence-Response Data at 460 mu
Since the predicted peak of the final action spectrum is 464
mu, the full data complement, from raw melatonin values to a
final fluence-response curve for the nearby monochromatic
stimulus at 460 mu, is illustrated in FIGS. 2-4. This fluence-
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response study at 460 mu was done with 8 subjects (4 males,
4 females). Across these subjects on all nights of testing, there
were no significant differences (F-0.70, p-0.69) between
sets of pre-exposure values indicating that baseline nocturnal
5 melatonin levels were consistent across the different nights of
study. FIG. 6 shows the mean+SEM pre- and post-exposure
(2:00 to 3:30 AM) melatonin values (mean range 72.1-29.3
pg/ml). At 460 nin, exposure to irradiances of 2.3 ltW/cm2 and
lower did not significantly suppress plasma melatonin. In
10 contrast, exposures of 3.1 µW/cm 2 and higher elicited signifi-
cant melatonin suppressions (p<0.03 or less).
For comparative purposes, all melatonin data were con-
verted to plasma melatonin percent control-adjusted change
scores. As illustrated in FIG. 7, one-way, repeated measures
15 ANOVA showed a significant effect of light intensity on
plasma melatonin percent control-adjusted change scores
(F=14.92, p<0.0001). Post-hoc tests on plasma melatonin
percent control-adjusted scores demonstrated that all intensi-
ties at or above 3.1 l W/cm2 significantly suppressed melato-
20 nin more than 0.012 µW/cm 2 (p<0.05 or less). Similarly, all
irradiances at or above 12.1 µW/cm 2 significantly suppressed
melatonin more than 1.5 µW/cm2 . Finally, both 24.2 and 42.2
µW/cm2 exposures elicited significantly higher plasma mela-
tonin percent control-adjusted change scores compared to an
25 irradiance of 2.3 ltW/cm2.
The data from FIG. 7 can be mathematically converted into
a best fit, sigmoidal curve which plots melatonin suppression
against stimulus photon density. The specific formula for this
curve is shown below and has a 0.97 coefficient of correlation
30 (p2)
7.17-73.4
+ 73.4Y
- 1+(x/8.29)123
35
As shown in FIG. 8, this curve illustrates the fluence-response
interaction between mean±SEM melatonin percent control-
40 adjusted change scores and the photon density of the mono-
chromatic light.
Fluence-Response Data for all 8 Wavelengths
As shown in FIGS. 6-8, there is a clear, fluence-response
relationship between graded photon densities of monochro-
45 matic 460 nm light and melatonin suppression. Data from
each of the 8 wavelengths tested in this study fit four-param-
eter sigmoidal curves with high coefficients of correlation.
Specifically, wavelengths at 440, 460, 480, 505, 530, 555, 575
and 600 mu had respective coefficients of correlation (R2):
50 0.99, 0.97, 0.95, 0.97, 0.98, 0.92, 0.96, and 0.97. As described
in the Methods, to form an analytical action spectrum, all
fluence-response curves must be fit to a univariant sigmoidal
curve (Lipson, 1994; Coohill, 1999). The univariant curve
model for the data in this study has the factors of AiO,
55 A2=66.9, and p=1.27. FIG. 5 illustrates all 8 univariant flu-
ence-response curves from this study. As with previous cir-
cadian analytical action spectra (Takahashi et al., 1984;
Provencio and Foster, 1995; Yoshimura and Ebihara, 1996),
full range fluence-response curves were not elicited above
60 550 mu. Despite this, standard photobiological curve fitting
methods could be used to fit the data from all eight wave-
lengths in the present study to univariant, sigmoidal func-
tions. When fit to a univariant fluence-response curve with
these factors, the data from exposures to 440, 460, 480, 505,
65 530, 555, 575 and 600 mu have high coefficients of correla-
tion of 0.91, 0.95, 0.93, 0.94, 0.92, 0.90, 0.95, and 0.81,
respectively.
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Melatonin Suppression Response to 420 nm at a Single 	 study. As shown in the 2:00 AM melatonin values (FIG. 6),
Intensity	 there were no significant differences between sets of pre-
Given the high sensitivity of subjects to short wavelength 	 exposure values indicating that baseline melatonin levels
light as shown in FIG. 9, it was determined that a probe of 	 were consistent across the different study nights. This phe-
sensitivity to monochromatic light below 440 mu was needed. 5 nomenon has been documented for the 505 nm fluence-re-
On the control night when the eight volunteers were exposed 	 sponse group as well as in other similarly controlled studies
to darkness only, their raw mean melatonin levels at 2:00 and
	 (Brainard et al., 1997; 2000; 2001; Wang et al., 1998). This
3:30 AM were 69.4 and 76.0 pg/ml, respectively. That small 	 within-subject stability of the melatonin rhythm over time has
increase was not statistically significant (t=1.15, p-0.29). 	 been frequently confirmed in the literature (Waldhauser and
As shown in FIG. 10, when these volunteers were exposed to io Dietzel, 1985; Arendt 1988; 1998).
420 mu light at 31.8 µW/cm2 (5.58x1013 photons/cm2), raw	 The data from each wavelength studied fit a univariant four
mean melatonin levels at 2:00 and 3:30 AM were 76.4 and 	 parameter sigmoidal curve with a high coefficient of correla-
47.6 pg/ml, respectively. That decrease in melatonin was 	 tion. The univariance of these curves is consistent with, but
statistically significant (t-4.67, p<0.003). For comparative 	 does not prove, the hypothesis that melatonin suppression is
purposes, this single melatonin suppression response was 15 modulated by a single photoreceptor type. Previous studies
fitted to the univariant fluence-response curve formula used 	 with animals and humans have illustrated similar fluence-
for all of the data in FIG. 9. The resulting curve estimated a 	 response relationships for melatonin suppression and other
half-maximum (X50 or ED50) melatonin suppression	 circadian responses with monochromatic and broad spectrum
response for 420 nm of 1.83x10 13 photons/cm2.	 light (Brainard et al., 1983; 1988; Podolin et al., 1987; McIn-
Action Spectrum for Melatonin Suppression 	 20 tyre et al., 1989; Nelson and Takahashi, 1991; Zeitzer et al.,
Action spectra are determined by comparing the number of 	 2000; Dkhissi-Benyahya et al., 2000). The initial attempts to
photons required for the same biological effect at different 	 define circadian and neuroendocrine responses to photons of
wavelengths (Smith, 1989; Coohill, 1999). For this experi- 	 different wavelength began with polychromatic action spec-
ment, the action spectrum was formed from the photon den-	 tra which tested single irradiances of broader light band-
sity which elicited the half-saturation constant (X 50 or ED50) 25 widths in various rodent species. These polychromatic action
of the percent control-adjusted melatonin suppression for	 spectra were reasonably consistent in indicating that the spec-
each of the eight wavelengths. The half-saturation constants 	 tral region between 450-550 mu provides the strongest stimu-
were derived from the eight univariant fluence-response	 lation of circadian and neuroendocrine responses in rodents
curves shown in FIG. 9 and the one estimated half-saturation 	 (for review: Brainard et al., 1999). Analytic action spectra,
constant from the data shown in FIG. 10. The relative quan- 3o based on sets of fluence-response curves at different mono-
tum sensitivity from each group of subjects was plotted in 	 chromatic wavelengths, are superior for identifying photore-
FIG. 11 (quanta/wavelength) to illustrate the resultant action	 ceptors that mediate photobiological responses (Lipson,
spectra for human melatonin suppression. When the data 	 1994; Coohill, 1999).
were aligned to the best-fit template for vitamin A,-retinal- 	 There are four analytic action spectra on circadian and
dehyde photopigments, this action spectrum predicted a peak 35 neuroendocrine regulation in hamsters, rats and mice (Taka-
spectral sensitivity (1 max) of 464 nm. There was a strong	 hashi et al., 1984; Bronstein et al., 1987; Provencio and Fos-
coefficient of correlation between the data and this fitted 	 ter, 1995; Yoshimura and Ebihara, 1996). Data from these
opsin nomogram (R2-0.91). 	 action spectra have been fitted to spectral sensitivity curves
Comparison of Action Spectra	 for retinal-based visual photopigments. This curve fitting is
The action spectrum for the photoreceptor system which 40 predicated on the assumption that a retinal-based molecule
provides input to the pineal gland appears to be distinct from	 transduces light stimuli for circadian regulation, and allows
the action spectra for the classical human visual photorecep- 	 the prediction of the shape of the photopigment absorption
tor systems. To illustrate this, the maximal spectral absorben- 	 spectrum as well as its peak sensitivity (1 max). Across these
cies and long wavelength limbs of the human rod and cone 	 studies which employed different circadian endpoints, the
photoreceptors that support vision (Stockman and Sharpe, 45 predicted 1 max ranges from 480-511 mu and is surrounded
1999) are illustrated in FIG. 8 along with the maximal spec- 	 by a broad region of high sensitivity. From these results,
tral absorbence and long wavelength limb of the melatonin 	 different photopigments have been suggested to be respon-
action spectrum. The shaded area around the melatonin action	 sible for circadian regulation, including rhodopsin, a rhodop-
spectrum illustrates±SD for this function. 	 sin-like molecule, a middle wavelength cone photopigment
Discussion of Action Spectra	 50 or an ultraviolet cone photopigment.
The action spectrum presented here is based on univariant 	 It is commonly believed that the photopic visual system has
fluence-response curves for melatonin suppression by eight 	 a peak wavelength sensitivity around 555 mu (Rodieck,
monochromatic light wavelengths in healthy subjects. These 	 1998). Many investigators have hypothesized that the photo-
data fit a vitamin A, opsin template with 446-477 mu provid- 	 pic visual system mediates circadian and neuroendocrine
ing the strongest circadian input for melatonin regulation. 55 responses, since this part of the visual system is responsive to
These results suggest a novel photopigment in the human eye	 "bright" daytime levels of illumination. Previous data (Brain-
may be primarily responsible for melatonin regulation and	 ard et al., 2001) and those presented above do not support this
may be distinct from the individual rod and cone photorecep-	 view. The results clearly demonstrate that 555 nm is signifi-
tors for vision.	 cantly weaker in suppressing melatonin compared to an equal
In developing a fluence-response curve, a complete within- 60 photon density of 460 nm. Thus, the photopic system is not
subjects experimental design produces the most reliable 	 likely to be the primary input for circadian regulation. Dem-
results. When subjects are studied over a two to four month 	 onstrating that the photopic visual system is not the principal
period, however, lack of stability in the subjects' circadian 	 phototransducer for melatonin regulation does not preclude it
entrainment can introduce variability in light-induced mela- 	 from having any role in circadian input. Indeed, recent studies
tonin suppression. This study accepted only volunteers who 65 suggest that visual cones may be involved in circadian regu-
reported regular bed and wake times and their melatonin 	 lation. Recordings from SCN neurons in rats indicate that the
rhythms appeared to have been stable during the course of the 	 visual rods and cones provide input to cells of the rat SCN
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(Aggelopoulos and Meissl, 2000). Similarly, a human phase- 	 visual performance, visual comfort, and aesthetic apprecia-
shifting study suggests that, under some circumstances, the 	 tion within the environment. Since light is also a powerful
visual long wavelength-sensitive cone may also mediate cir- 	 regulator of the human circadian system, future lighting strat-
cadian vision in humans (Zeitzer et al., 1997). 	 egies will need to provide illumination for human visual
The data presented here do not support the view that any of 5 responses as well as homeostatic responses. The action spec-
the known visual photoreceptors provide the primary input 	 trum presented here suggests that there are separate photore-
for melatonin regulation. FIG. 10 shows that none of the 	 ceptors for visual and circadian responses to light in humans.
action spectra for individual visual photoreceptor systems 	 Hence, new approaches to architectural lighting may be
match the action spectrum for melatonin suppression. If the	 needed to optimally stimulate both the visual and circadian
photoreceptors that mediate vision in humans are not the 10 systems.
primary photoreceptors for circadian regulation, what are the 	 In conclusion, this study characterizes the wavelength sen-
alternative candidates? Recent studies withvarious vertebrate 	 sitivity of the ocular photoreceptor system for regulating the
species have identified several new molecules which may	 human pineal gland by establishing an action spectrum for
serve as circadian photopigments. These putative photopig- 	 light-induced melatonin suppression. The results identify
ments include both opsin-based molecules such as vertebrate 15 446-477 nm portion of the spectrum as the most potent wave-
ancient (VA) opsin (Soni and Foster, 1997), melanopsin	 lengths providing circadian input for regulating melatonin
(Provencio et al., 1998), and peropsin (Sun et al., 1997), as 	 secretion. These data suggest that the primary photoreceptor
well as non-opsin molecules like biliverdin (Oren, 1996) and	 system for melatonin suppression is distinct from the rod and
cryptochrome (Miyamoto and Sancar, 1998). Among these	 cone photoreceptors for vision. Finally, this action spectrum
new photopigments, only melanopsin has been specifically 20 suggests that there is a novel retinaldehyde photopigment
localized to the human neural retina (Provencio et al., 2000)	 which mediates human circadian photoreception. These find-
and cryptochrome has been localized to the mouse neural
	
ings open the door for optimizing the utilization of light in
retina (Miyamoto and Sancar, 1998). Cryptochromes have 	 both therapeutic and architectural applications.
been studied extensively as circadian photoreceptors in plants
and insects (Ahmad and Cashmore, 1993; Stanewsky et al., 25	 REFERENCES
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What is claimed is:
1. A method of at least treating or preventing at least one
light responsive disorder in at least one mammal, said method
io comprising the steps of: utilizing at least one light source, said
at least one light source emitting optical radiation; causing
said optical radiation to be commonly therapeutically effec-
tive in humans by employing a pre-established spectral com-
position that has been pre-identified as a maximally potent
i5 spectral composition in the regulation of at least one of the
human circadian, photoneural, or neuroendocrine systems,
said pre-established spectral composition comprising at least
one enhanced spectral region comprising at least one peak of
emitted light within the range of 435-488 mu;
20 exposing at least a portion of the retina of at least one eye
of at least one mammal to said pre-established spectral
composition of optical radiation such that said light
source is not mounted on the body of said at least one
mammal;
25 stimulating the photoreceptor system for at least one of the
circadian, photoneural or neuroendocrine systems of
said at least one mammal;
and, enabling at least the treatment or the prevention of at
least one light responsive disorder in said at least one
so	 mammal.
2. The method of claim 1, said method further comprising
providing at least one light filtering component in conjunc-
tion with said at least one light source; and
35	 causing said at least one light filtering component to trans-
mit therapeutically effective optical radiation.
3. The method of claim 2 wherein said method further
comprises providing at least one transparent composition in
conjunction with said at least one light filtering component.
40 4. The method of claim 2 wherein said method further
comprises providing at least one translucent composition in
conjunction with said at least one light filtering component.
5. The method of 2 wherein said light filtering component
further comprises at least one translucent composition.
45	 6. The method of claim 1, said method further comprising
enabling the prevention of at least one light responsive
disorder in said at least one mammal.
7. The method of claim 6, said method further comprising
providing at least one light filtering component in conjunc-
50 tion with said at least one light source; and
causing said at least one light filtering component to trans-
mit therapeutically effective optical radiation.
8. The method of claim 7 wherein said method further
comprises providing at least one transparent composition in
55 conjunction with said at least one light filtering component.
9. The method of claim 7 wherein said method further
comprises providing at least one translucent composition in
conjunction with said at least one light filtering component.
